Atezolizumab (Ingredient)
Drugbank ID: DB11595
The information below refers to products available in the United States that contain atezolizumab.
Products containing atezolizumab
atezolizumab systemic
Brand name: Tecentriq
Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
Atezolizumab systemic is used in the treatment of:
- Alveolar Soft Part Sarcoma
- Bladder Cancer
- Breast Cancer
- Hepatocellular Carcinoma
- Melanoma
- Non Small Cell Lung Cancer
- Small Cell Lung Cancer
- Urothelial Carcinoma
Multi-ingredient medications containing atezolizumab
atezolizumab/hyaluronidase systemic
Brand name: Tecentriq Hybreza
Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
Atezolizumab/hyaluronidase systemic is used in the treatment of:
- Alveolar Soft Part Sarcoma
- Hepatocellular Carcinoma
- Melanoma
- Non Small Cell Lung Cancer
- Small Cell Lung Cancer
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.